David Isaacs
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
David Isaacs has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
Dominic Fitzgerald
Department of Respiratory Medicine, Children’s Hospital at Westmead
10 shared publicationsStephen Isaacs
London UK
8 shared publicationsBernadette Tobin
Plunkett Centre for Ethics in Health Care, St Vincent's Hospital and Australian Catholic University, Sydney, New South Wales, Australia
7 shared publications- Henry Kilham
Clinical Ethics Children's Hospital at Westmead Sydney New South Wales Australia
4 shared publications B Tobin
Plunkett Centre for Ethics in Health Care, St Vincent's Hospital, Darlinghurst, New South Wales, Australia
2 shared publicationsD Fitzgerald
Children’s Hospital at Westmead, Westmead, NSW, 2145, Australia
2 shared publications
Latest Publications
- 2 June 2017
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 53 (6) , 523-524
Female genital mutilation and the role of health-care practitioners
- 2 June 2017
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 53 (6) , 523-524
Female genital mutilation and the role of health-care practitioners
- 3 May 2015
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 51 (5) , 471-472
Medical marijuana
- 3 May 2015
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 51 (5) , 471-472
Medical marijuana
- 6 November 2014
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 50 (11) , 845-846
Transitional objects and thumb sucking
- 6 November 2014
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 50 (11) , 845-846
Transitional objects and thumb sucking
- 18 December 2012
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 49 (3) , E243-E245
Recurrent fevers
- 18 December 2012
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 49 (3) , E243-E245
Recurrent fevers
- 11 December 2012
- Published by Springer Nature
- Vol. 764, 151-158
Infectious Risks Associated with Biologics
Biologics are generally either custom-designed monoclonal antibodies against specific target cells (e.g. B-cells) or target cytokines (e.g. tumour necrosis factor, TNF) or they are receptor constructs (fusion proteins) based on naturally-occurring cytokine or cell receptors. Biologics are mostly used in adult rheumatology but are increasingly used in paediatrics. There are significant concerns about safety and also about cost. The main safety concerns are about increased risk of infection and malignancy. The use of TNF antagonists is associated with increased risk of serious infections with intracellular organisms, particularly mycobacteria, but also intracellular bacteria, fungi and Pneumocystis. B-cell antagonists like rituximab can cause progressive multifocal leukoencephalopathy. IL-6 antagonists are associated with increased rates of common bacterial infections and the complement pathway antagonist eculizumab with meningococcal infection. The risk of some infections associated with biologics can be reduced, by screening patients starting TNF antagonists for latent tuberculosis and giving them cotrimoxazole prophylaxis against Pneumocystis, and by immunising against VZV, hepatitis B, meningococci and pneumococci. However, the risk of the biologics causing serious infection in children is unknown and needs study. Children should not be started on the biologics without careful consideration of the risks and without fully informed consent.
- 11 December 2012
- Published by Springer Nature
- Vol. 764, 151-158
Infectious Risks Associated with Biologics
Biologics are generally either custom-designed monoclonal antibodies against specific target cells (e.g. B-cells) or target cytokines (e.g. tumour necrosis factor, TNF) or they are receptor constructs (fusion proteins) based on naturally-occurring cytokine or cell receptors. Biologics are mostly used in adult rheumatology but are increasingly used in paediatrics. There are significant concerns about safety and also about cost. The main safety concerns are about increased risk of infection and malignancy. The use of TNF antagonists is associated with increased risk of serious infections with intracellular organisms, particularly mycobacteria, but also intracellular bacteria, fungi and Pneumocystis. B-cell antagonists like rituximab can cause progressive multifocal leukoencephalopathy. IL-6 antagonists are associated with increased rates of common bacterial infections and the complement pathway antagonist eculizumab with meningococcal infection. The risk of some infections associated with biologics can be reduced, by screening patients starting TNF antagonists for latent tuberculosis and giving them cotrimoxazole prophylaxis against Pneumocystis, and by immunising against VZV, hepatitis B, meningococci and pneumococci. However, the risk of the biologics causing serious infection in children is unknown and needs study. Children should not be started on the biologics without careful consideration of the risks and without fully informed consent.
- 31 August 2012
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 98 (3) , F249-F255
Neonatal infections in China, Malaysia, Hong Kong and Thailand
Objective: Neonatal sepsis is a major cause of neonatal deaths in Asia but data remain scarce. We aimed to investigate the causative organisms and antibiotic resistance in neonatal care units in China, Malaysia, Hong Kong and Thailand. Methods: Prospective cohort study of neonatal sepsis defined as positive culture of a single potentially pathogenic organism from blood or cerebrospinal fluid differentiated into early-onset sepsis (EOS) occurring Streptococcus (GBS) sepsis was low but remained the most common single pathogen for EOS among inborn babies. Klebsiella spp. was the most common Gram-negative organism causing most deaths. The case-fatality was 7.0% (95% CI 3.9% to 12.0%) for EOS and 16.0% (95% CI 13.7% to 19.0%) for LOS, and was significantly different between participating units after adjusting for potential confounders. Of all Gram-negative organisms, 47%, 37% and 32% were resistant to third-generation cephalosporins, gentamicin or both, respectively. Conclusions: The pattern of EOS in Asian settings is similar to that in industrialised countries with low incidence of GBS sepsis. The important features of neonatal sepsis in Asia are the burden of Klebsiella spp. and high level of antibiotic resistance. These should be addressed while developing measures to reduce neonatal mortality due to infection.
- 31 August 2012
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 98 (3) , F249-F255
Neonatal infections in China, Malaysia, Hong Kong and Thailand
Objective: Neonatal sepsis is a major cause of neonatal deaths in Asia but data remain scarce. We aimed to investigate the causative organisms and antibiotic resistance in neonatal care units in China, Malaysia, Hong Kong and Thailand. Methods: Prospective cohort study of neonatal sepsis defined as positive culture of a single potentially pathogenic organism from blood or cerebrospinal fluid differentiated into early-onset sepsis (EOS) occurring Streptococcus (GBS) sepsis was low but remained the most common single pathogen for EOS among inborn babies. Klebsiella spp. was the most common Gram-negative organism causing most deaths. The case-fatality was 7.0% (95% CI 3.9% to 12.0%) for EOS and 16.0% (95% CI 13.7% to 19.0%) for LOS, and was significantly different between participating units after adjusting for potential confounders. Of all Gram-negative organisms, 47%, 37% and 32% were resistant to third-generation cephalosporins, gentamicin or both, respectively. Conclusions: The pattern of EOS in Asian settings is similar to that in industrialised countries with low incidence of GBS sepsis. The important features of neonatal sepsis in Asia are the burden of Klebsiella spp. and high level of antibiotic resistance. These should be addressed while developing measures to reduce neonatal mortality due to infection.
- 1 May 2012
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 31 (5) , 521-523
Vitamin D and Tuberculosis Status in Refugee Children
Vitamin D deficiency and tuberculosis (TB) are associated in adults, but data in children are scarce. We screened refugee children routinely for vitamin D status and TB. Vitamin D values were significantly lower in latent TB (n = 81) and TB infection (n = 11) than in children without TB (n = 236). We conclude that refugee children with TB have reduced vitamin D levels.
- 1 May 2012
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 31 (5) , 521-523
Vitamin D and Tuberculosis Status in Refugee Children
Vitamin D deficiency and tuberculosis (TB) are associated in adults, but data in children are scarce. We screened refugee children routinely for vitamin D status and TB. Vitamin D values were significantly lower in latent TB (n = 81) and TB infection (n = 11) than in children without TB (n = 236). We conclude that refugee children with TB have reduced vitamin D levels.
- 15 November 2011
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 47 (11) , 761-762
The power of play
- 15 November 2011
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 47 (11) , 761-762
The power of play
- Open Access
- 17 October 2011
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 47 (10) , 679-680
Conflict of interest: No such thing as a free lunch
- 17 October 2011
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 47 (10) , 679-680
Open AccessConflict of interest: No such thing as a free lunch
- Open Access
- 27 September 2011
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 47 (9) , 677
Comment by the Editor-in-Chief
- 27 September 2011
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 47 (9) , 677
Open AccessComment by the Editor-in-Chief